July 22, 2021
FinanzNachrichten
Endo Announces Agreement in Principle to Settle Tennessee State Court Case
DUBLIN, July 22, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) today announced that its ... See more »
1,272 Followers on Owler
Endo
Endo is a pharmaceutical company that researches, develops and commercializes therapeutics for the treatment of genetic disorders and kidney diseases.
Read more
President & CEO
Blaise Coleman
Missing a competitor? Contribute!
Mylan is Endo's top competitor. Mylan was founded in 1961 in Canonsburg, Pennsylvania. Mylan competes in the Pharmaceuticals field. Mylan generates $8.7B more revenue than Endo.
Trending News for Endo and Endo's Competitors
July 23, 2021
Pharmaceutical Processing World
Takeda and Capsida announce manufacturing plant investments in California
Takeda Pharmaceuticals (NYSE:TAK) has announced that it is investing $126 million to expand a product... See more »
July 23, 2021
Korea Biomedical Review
Handok to sell Jazz Pharmaceuticals' leukemia drug in Korea exclusively
Handok signed an agreement to exclusively market Jazz Pharmaceuticals' acute myeloid leukemia (AML) t... See more »
Endo Quarterly and Annual Revenue
Trailing 12-Months Trend (TTM)
Annual Revenue
$2.8B
Endo's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 9.7B. Over the last four quarters, Endo's revenue has grown by 4.4%. Specifically, in Q1 2021's revenue was $717.9M; in Q4 2020, it was $760.2M; in Q3 2020, it was $634.9M; in Q2 2020, Endo's revenue was $687.6M.
Endo Acquisitions
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Biospecifics Technologies Corp
Oct 2020
Source »$120M
BioSpecifics is a biopharmaceutical firm that develops collagenase-based therapies for the treatment of Dupuytren contracture and Peyronie diseases.
Somerset Therapeutics, LLC
Apr 2018
Source »$190M
Somerset is a sterile pharmaceutical company that manufactures and markets injectable and ophthalmic drugs for the US marketplace.
Par Pharmaceutical
May 2015
Source »$8.1B
Par Pharmaceutical develops, manufactures and markets generic and branded specialty pharmaceutical products in the United States.
Auxilium Pharmaceuticals Inc
Oct 2014
Source »$2.6B
Auxilium Pharmaceuticals provides healthcare services.
These are all the companies that Endo has acquired. Endo has acquired 9 companies and its latest acquisition was Biospecifics Technologies Corp in Oct 2020. BioSpecifics is a biopharmaceutical firm that develops collagenase-based therapies for the treatment of Dupuytren contracture and Peyronie diseases.
Endo Funding History
Since Endo was founded in 1997, it has participated in 2 rounds of funding. In total Endo has raised $2.8B. Endo's last funding round was on Jun 2020 for a total of $2.8B
Endo Investments
No recent investments found related to Endo
Endo News
Endo Press Releases
Social Media
Endo Headquarters
Simmonscourt Road First Floor, Minerva House
Ballsbridge, County Dublin
353-1-268-2000
Driving Directions »Trending Companies
IN THE NEWS
Cousins Furniture Stores | Hibbett | Lowenstein Sandler | Camden | Mylan | Cohesionmarketingpartners | Wockhardt | Zimmer Biomet | Triller | Sysco | Mccarthy | Apple | Schlumberger | Allied BioScience | Eli Lilly | First Financial Bank | Discovery | O'Reilly Auto Parts | Apexwin | Android | Scotiabank | Coca-Cola | Micron | Cadence | Digital Realty | ISA | ICE | JPMorgan Chase | Rowing Blazers By Jack Carlson | Amgen | Pathbreaker Ventures | Vince | Reddington Hospital | Eclipse | John Lewis | Prime Planet Energy & Solutions | Orocobre | Teamworthy | Galaxy ME | Gramercy Surgery Center | King | Eaton Vance | FAR Resources | molzi | Analog Devices | Carloadexpress | Akamai | Guidewire | Numotion | Hilton
PEOPLE ALSO VIEWED
ClearLabs | Miltenyi Biotec | Hetero | GenScript | AmerisourceBergen | Smith Drug Company | GreenLight | Immatics | Illumina | Zymo Research | BioFire Diagnostics | Arbor Pharmaceuticals | Kite Pharma | PGDx | Zynerba | SingEx | Metaswitch | Springer Nature | Xcenda | Cause Match | Bioriginal | Empire Genomics | Novan | Emmes | ALX Oncology | BeathChapman | J.k. Fenner (India) | Ryderwear | Bnd Fashions | MarketLine
Endo Summary
ABOUT
Overview
Endo is a pharmaceutical company that researches, develops and commercializes therapeutics for the treatment of genetic disorders and kidney diseases. Endo was founded in 1997. Endo's headquarters is located in Ballsbridge, County Dublin, IE . It has ...
CEO
Endo's President & CEO, Blaise Coleman, currently has an approval rating of 88%. Endo's primary competitors are Mylan, Allergan & Jazz Pharmaceuticals.Website
endo.comFrequently Asked Questions about Endo
When was Endo founded?
Endo was founded in 1997Who is Endo's CEO?
Endo's CEO is Blaise ColemanHow much revenue does Endo generate?
Endo generates $2.8B in revenueHow much funding does Endo have?
Endo has historically raised $2.8B in funding
Where is Endo's headquarters?
Endo's headquarters is in Ballsbridge County Dublin, IEHow many employees does Endo have?
Endo has 2,910 employeesWho are Endo's competitors?
Endo's top competitors are Mylan, Allergan, Jazz Pharmaceuticals
